| 000 | 01635 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514160358.0 | ||
| 264 | 0 | _c20040319 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/wnl.61.7.909 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWohlgemuth, M | |
| 245 | 0 | 0 |
_aPossible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles. _h[electronic resource] |
| 260 |
_bNeurology _cOct 2003 |
||
| 300 |
_a909-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aChromosomes, Human, Pair 4 _xgenetics |
| 650 | 0 | 4 | _aCytogenetic Analysis |
| 650 | 0 | 4 | _aElectrophoresis, Gel, Pulsed-Field |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Dosage |
| 650 | 0 | 4 | _aGenes, Dominant |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscular Dystrophy, Facioscapulohumeral _xgenetics |
| 650 | 0 | 4 | _aPedigree |
| 650 | 0 | 4 | _aPenetrance |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aRepetitive Sequences, Nucleic Acid |
| 650 | 0 | 4 | _aRestriction Mapping |
| 700 | 1 | _aLemmers, R J | |
| 700 | 1 | _avan der Kooi, E L | |
| 700 | 1 | _avan der Wielen, M J | |
| 700 | 1 | _avan Overveld, P G | |
| 700 | 1 | _aDauwerse, H | |
| 700 | 1 | _aBakker, E | |
| 700 | 1 | _aFrants, R R | |
| 700 | 1 | _aPadberg, G W | |
| 700 | 1 | _avan der Maarel, S M | |
| 773 | 0 |
_tNeurology _gvol. 61 _gno. 7 _gp. 909-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.61.7.909 _zAvailable from publisher's website |
| 999 |
_c14300813 _d14300813 |
||